A Peptide Engineering Platform for PEG-FA Stapled Long-Acting Peptide Hormones
Weijun Shen
Director, Metabolic Diseases, CALIBR at Scripps Research
Not available
Weijun Shen currently works as Director, Metabolic Diseases at CALIBR, drug discovery arm of The Scripps Research Institute. Weijun does research in small molecule drug discovery and peptide engineering for cardiovascular diseases and diabetes, oncology, regenerative medicine.